Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH

NCT03350659 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Seoul National University Hospital

Collaborators